Exposure of breast cancer cell lines to doxorubicin, docetaxel, and therapy with selective estrogen receptor modulators (SERMs) resulted in selecting a chemoresistant population of cells with increased expression of Notch 1 and Notch 4 [20]. Here, NOTCH1 is linked to breast carcinoma.